{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:46:04Z","timestamp":1783003564395,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008397","name":"Velux Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Migraine is a disease characterized by cerebral vasodilation. While diabetes has previously been associated with a lower risk of migraine, it is not known if diabetic retinopathy (DR), a retinal peripheral vascular occlusive disease, is a potential biomarker of protection against migraine. Therefore, we aimed to examine diabetic retinopathy as a marker of prevalent and 5-year incident migraine. In a national cohort, we compared patients with diabetes attending DR screening from The Danish National Registry of Diabetic Retinopathy (cases, n\u2009=\u2009205,970) to an age- and gender-matched group of patients without diabetes (controls, n\u2009=\u20091,003,170). In the cross-sectional study, a multivariable model demonstrated a lower prevalence of migraine among cases compared with controls (OR 0.83, 95% CI 0.81\u20130.85), with a lower risk in cases with DR than in those without (OR 0.69, 95% CI 0.65\u20130.72). In the prospective study, a lower risk of incident migraine was found in a multivariable model in cases (HR 0.76, 95% CI 0.70\u20130.82), but this did not depend upon the presence of DR. To conclude, in a national study of more than 1.2 million people, patients screened for DR had a lower risk of present migraine, but DR was not a protective marker of incident migraine.<\/jats:p>","DOI":"10.1038\/s41598-022-16793-0","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T17:03:08Z","timestamp":1658336588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of the correlation between diabetic retinopathy and prevalent and incident migraine in a national cohort study"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0124-7542","authenticated-orcid":false,"given":"Anna Stage","family":"Vergmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonny","family":"Stokholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine Hass","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Thykj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"M\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Schmidt","family":"Laugesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Heegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"H\u00f8jlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja Christina","family":"Schielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Grauslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"16793_CR1","unstructured":"World Health Organization and Lifting the burden: Atlas of Headache Disorders and Resources in the World (2011)."},{"issue":"06","key":"16793_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1055\/s-0037-1607393","volume":"37","author":"SW Broner","year":"2017","unstructured":"Broner, S. W., Bobker, S. & Klebanoff, L. Migraine in women. Semin. Neurol. 37(06), 601\u2013610 (2017).","journal-title":"Semin. Neurol."},{"issue":"4","key":"16793_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1468-1331.2006.01184.x","volume":"13","author":"LJ Stovner","year":"2006","unstructured":"Stovner, L. J., Zwart, J. A., Hagen, K., Terwindt, G. M. & Pascual, J. Epidemiology of headache in Europe. Eur. J. Neurol. 13(4), 333\u2013345 (2006).","journal-title":"Eur. J. Neurol."},{"issue":"6","key":"16793_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s10194-007-0427-2","volume":"8","author":"M Piane","year":"2007","unstructured":"Piane, M. et al. Genetics of migraine and pharmacogenomics: Some considerations. J. Headache Pain 8(6), 334\u2013339 (2007).","journal-title":"J. Headache Pain"},{"issue":"10","key":"16793_CR5","doi-asserted-by":"publisher","first-page":"e110530","DOI":"10.1371\/journal.pone.0110530","volume":"9","author":"C Fern\u00e1ndez-de-las-Pe\u00f1as","year":"2014","unstructured":"Fern\u00e1ndez-de-las-Pe\u00f1as, C. et al. Has the prevalence of migraine changed over the last decade (2003\u20132012)? A Spanish population-based survey. PLoS ONE 9(10), e110530 (2014).","journal-title":"PLoS ONE"},{"issue":"1","key":"16793_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40200-016-0241-y","volume":"15","author":"FS Haghighi","year":"2016","unstructured":"Haghighi, F. S. et al. Migraine and type 2 diabetes; is there any association?. J. Diabetes Metab. Disord. 15(1), 37 (2016).","journal-title":"J. Diabetes Metab. Disord."},{"issue":"3","key":"16793_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/0333102417690488","volume":"38","author":"K Hagen","year":"2017","unstructured":"Hagen, K. et al. Inverse relationship between type 1 diabetes mellitus and migraine. Data from the Nord-Tr\u00f8ndelag Health Surveys 1995\u20131997 and 2006\u20132008. Cephalalgia 38(3), 417\u2013426 (2017).","journal-title":"Cephalalgia"},{"issue":"1","key":"16793_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/EDE.0b013e31827623d0","volume":"24","author":"LI Berge","year":"2013","unstructured":"Berge, L. I. et al. Does diabetes have a protective effect on migraine?. Epidemiology 24(1), 129\u2013134 (2013).","journal-title":"Epidemiology"},{"key":"16793_CR9","doi-asserted-by":"publisher","first-page":"i2610","DOI":"10.1136\/bmj.i2610","volume":"353","author":"T Kurth","year":"2016","unstructured":"Kurth, T. et al. Migraine and risk of cardiovascular disease in women: Prospective cohort study. BMJ 353, i2610 (2016).","journal-title":"BMJ"},{"issue":"9","key":"16793_CR10","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/j.1526-4610.2008.01277.x","volume":"48","author":"FM Cutrer","year":"2008","unstructured":"Cutrer, F. M. & Charles, A. The neurogenic basis of migraine. Headache J. Head Face Pain 48(9), 1411\u20131414 (2008).","journal-title":"Headache J. Head Face Pain"},{"key":"16793_CR11","unstructured":"Federation ID: IDF Diabetes Atlas, 9th edn. https:\/\/www.diabetesatlas.org (2019)."},{"issue":"2","key":"16793_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/med.10024","volume":"23","author":"A Martin","year":"2003","unstructured":"Martin, A., Komada, M. R. & Sane, D. C. Abnormal angiogenesis in diabetes mellitus. Med. Res. Rev. 23(2), 117\u2013145 (2003).","journal-title":"Med. Res. Rev."},{"issue":"4","key":"16793_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1152\/physiol.00039.2016","volume":"32","author":"N Sawada","year":"2017","unstructured":"Sawada, N. & Arany, Z. Metabolic regulation of angiogenesis in diabetes and aging. Physiology 32(4), 290\u2013307 (2017).","journal-title":"Physiology"},{"issue":"5","key":"16793_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1161\/01.STR.0000068781.31429.BE","volume":"34","author":"K Hosoda","year":"2003","unstructured":"Hosoda, K. et al. Prediction of hyperperfusion after carotid endarterectomy by brain SPECT analysis with semiquantitative statistical mapping method. Stroke 34(5), 1187\u20131193 (2003).","journal-title":"Stroke"},{"issue":"20","key":"16793_CR15","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1212\/01.wnl.0000261916.42871.05","volume":"68","author":"KM Rose","year":"2007","unstructured":"Rose, K. M. et al. Migraine and retinal microvascular abnormalities. Neurology 68(20), 1694 (2007).","journal-title":"Neurology"},{"issue":"9735","key":"16793_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung, N., Mitchell, P. & Wong, T. Y. Diabetic retinopathy. Lancet 376(9735), 124\u2013136 (2010).","journal-title":"Lancet"},{"issue":"7160","key":"16793_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"Group UPDS","year":"1998","unstructured":"Group UPDS. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317(7160), 703 (1998).","journal-title":"BMJ"},{"issue":"14","key":"16793_CR18","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"Trial DCaC","year":"1993","unstructured":"Trial DCaC. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329(14), 977\u2013986 (1993).","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"16793_CR19","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1016\/j.ophtha.2014.07.019","volume":"121","author":"EY Chew","year":"2014","unstructured":"Chew, E. Y. et al. The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology 121(12), 2443\u20132451 (2014).","journal-title":"Ophthalmology"},{"issue":"5","key":"16793_CR20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0002-9394(01)01124-2","volume":"132","author":"LP Aiello","year":"2001","unstructured":"Aiello, L. P., Cahill, M. T. & Wong, J. S. Systemic considerations in the management of diabetic retinopathy. Am. J. Ophthalmol. 132(5), 760\u2013776 (2001).","journal-title":"Am. J. Ophthalmol."},{"key":"16793_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2147\/CLEP.S99507","volume":"8","author":"N Andersen","year":"2016","unstructured":"Andersen, N. et al. The Danish Registry of diabetic retinopathy. Clin. Epidemiol. 8, 613\u2013619 (2016).","journal-title":"Clin. Epidemiol."},{"issue":"9","key":"16793_CR22","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson, C. P. et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110(9), 1677\u20131682 (2003).","journal-title":"Ophthalmology"},{"issue":"7","key":"16793_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"H Wallach Kildemoes","year":"2011","unstructured":"Wallach Kildemoes, H., Toft S\u00f8rensen, H. & Hallas, J. The Danish National Prescription Registry. Scand. J. Public Health 39(7), 38\u201341 (2011).","journal-title":"Scand. J. Public Health"},{"issue":"7","key":"16793_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen, C. B. The Danish Civil Registration System. Scand. J. Public Health 39(7), 22\u201325 (2011).","journal-title":"Scand. J. Public Health"},{"key":"16793_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/aos.14415","volume":"98","author":"J Grauslund","year":"2020","unstructured":"Grauslund, J. et al. Interactions between ocular and systemic disease using national register-based data in the Danish Excellence Centre in Ophthalmic Epidemiology (DECODE-EYE): Study perspective. Acta Ophthalmol. 98, 573\u2013578 (2020).","journal-title":"Acta Ophthalmol."},{"issue":"6","key":"16793_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan, H. et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 173(6), 676\u2013682 (2011).","journal-title":"Am. J. Epidemiol."},{"issue":"10","key":"16793_CR27","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/j.1526-4610.2012.02223.x","volume":"52","author":"DC Buse","year":"2012","unstructured":"Buse, D. C. et al. Chronic migraine prevalence, disability, and sociodemographic factors: Results from the American Migraine Prevalence and Prevention Study. Headache 52(10), 1456\u20131470 (2012).","journal-title":"Headache"},{"key":"16793_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.autneu.2017.01.004","volume":"203","author":"L Babayan","year":"2017","unstructured":"Babayan, L., Mamontov, O. V., Amelin, A. V., Bogachev, M. & Kamshilin, A. A. Arterial hypertension in migraine: Role of familial history and cardiovascular phenotype. Auton. Neurosci. 203, 103\u2013107 (2017).","journal-title":"Auton. Neurosci."},{"key":"16793_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000096722","volume":"44","author":"J D\u00edez","year":"2007","unstructured":"D\u00edez, J. Arterial stiffness and extracellular matrix. Atheroscler. Large Arteries Cardiovasc. Risk. 44, 76\u201395 (2007).","journal-title":"Atheroscler. Large Arteries Cardiovasc. Risk."},{"issue":"1","key":"16793_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","volume":"17","author":"R Kaur","year":"2018","unstructured":"Kaur, R., Kaur, M. & Singh, J. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: Molecular insights and therapeutic strategies. Cardiovasc. Diabetol. 17(1), 121\u2013121 (2018).","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"16793_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.4103\/1673-5374.266910","volume":"15","author":"HR Mendonca","year":"2020","unstructured":"Mendonca, H. R., Carpi-Santos, R., da Costa, C. K. & Blanco Martinez, A. M. Neuroinflammation and oxidative stress act in concert to promote neurodegeneration in the diabetic retina and optic nerve: Galectin-3 participation. Neural Regen. Res. 15(4), 625\u2013635 (2020).","journal-title":"Neural Regen. Res."},{"key":"16793_CR32","doi-asserted-by":"publisher","first-page":"108498","DOI":"10.1016\/j.neuropharm.2021.108498","volume":"187","author":"KD Rolev","year":"2021","unstructured":"Rolev, K. D., Shu, X. S. & Ying, Y. Targeted pharmacotherapy against neurodegeneration and neuroinflammation in early diabetic retinopathy. Neuropharmacology 187, 108498 (2021).","journal-title":"Neuropharmacology"},{"issue":"3","key":"16793_CR33","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/jcm10030458","volume":"10","author":"M Mrugacz","year":"2021","unstructured":"Mrugacz, M., Bryl, A. & Zorena, K. Retinal vascular endothelial cell dysfunction and neuroretinal degeneration in diabetic patients. J. Clin. Med. 10(3), 458 (2021).","journal-title":"J. Clin. Med."},{"issue":"5","key":"16793_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/head.13529","volume":"59","author":"S Iyengar","year":"2019","unstructured":"Iyengar, S., Johnson, K. W., Ossipov, M. H. & Aurora, S. K. CGRP and the trigeminal system in migraine. Headache 59(5), 659\u2013681 (2019).","journal-title":"Headache"},{"key":"16793_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.visres.2017.03.013","volume":"139","author":"BA Coughlin","year":"2017","unstructured":"Coughlin, B. A., Feenstra, D. J. & Mohr, S. M\u00fcller cells and diabetic retinopathy. Vis. Res. 139, 93\u2013100 (2017).","journal-title":"Vis. Res."},{"issue":"38","key":"16793_CR36","doi-asserted-by":"publisher","first-page":"26395","DOI":"10.1074\/jbc.M114.583880","volume":"289","author":"Y Jiang","year":"2014","unstructured":"Jiang, Y. et al. Pioglitazone normalizes insulin signaling in the diabetic rat retina through reduction in tumor necrosis factor \u03b1 and suppressor of cytokine signaling 3. J. Biol. Chem. 289(38), 26395\u201326405 (2014).","journal-title":"J. Biol. Chem."},{"issue":"6","key":"16793_CR37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s40263-019-00630-6","volume":"33","author":"KA Haanes","year":"2019","unstructured":"Haanes, K. A. & Edvinsson, L. Pathophysiological mechanisms in migraine and the identification of new therapeutic targets. CNS Drugs 33(6), 525\u2013537 (2019).","journal-title":"CNS Drugs"},{"issue":"6","key":"16793_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jdiacomp.2013.08.001","volume":"27","author":"J-H Yang","year":"2013","unstructured":"Yang, J.-H. et al. STZ treatment induced apoptosis of retinal cells and effect of up-regulation of calcitonin gene related peptide in rats. J. Diabetes Complicat. 27(6), 531\u2013537 (2013).","journal-title":"J. Diabetes Complicat."},{"issue":"9786","key":"16793_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(11)60614-4","volume":"378","author":"CJ Nolan","year":"2011","unstructured":"Nolan, C. J., Damm, P. & Prentki, M. Type 2 diabetes across generations: From pathophysiology to prevention and management. Lancet 378(9786), 169\u2013181 (2011).","journal-title":"Lancet"},{"issue":"Suppl 1","key":"16793_CR40","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1111\/j.1526-4610.2005.4501001.x","volume":"45","author":"RB Lipton","year":"2005","unstructured":"Lipton, R. B. & Bigal, M. E. Migraine: Epidemiology, impact, and risk factors for progression. Headache 45(Suppl 1), S3-s13 (2005).","journal-title":"Headache"},{"issue":"11","key":"16793_CR41","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1111\/bcp.13705","volume":"84","author":"SR Sadat-Ebrahimi","year":"2018","unstructured":"Sadat-Ebrahimi, S. R. et al. An evidence-based systematic review of the off-label uses of lisinopril. Br. J. Clin. Pharmacol. 84(11), 2502\u20132521 (2018).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"16793_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s10194-020-01163-w","volume":"21","author":"ES Kristoffersen","year":"2020","unstructured":"Kristoffersen, E. S., B\u00f8rte, S., Hagen, K., Zwart, J. A. & Winsvold, B. S. Migraine, obesity and body fat distribution\u2014A population-based study. J. Headache Pain 21(1), 97 (2020).","journal-title":"J. Headache Pain"},{"key":"16793_CR43","doi-asserted-by":"publisher","first-page":"6585734","DOI":"10.1155\/2018\/6585734","volume":"2018","author":"Q Huang","year":"2018","unstructured":"Huang, Q., Liang, X., Wang, S. & Mu, X. Association between Body Mass Index and migraine: A survey of adult population in China. Behav. Neurol. 2018, 6585734 (2018).","journal-title":"Behav. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16793-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16793-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16793-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:30:49Z","timestamp":1669350649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16793-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16793"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16793-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"8 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12443"}}